Latest Insider Transactions at Amgen Inc (AMGN)
This section provides a real-time view of insider transactions for Amgen Inc (AMGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 30
2019
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-0.37%
|
$22,080
$192.11 P/Share
|
|
Jan 30
2019
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
142
-0.41%
|
$27,264
$192.11 P/Share
|
|
Dec 06
2018
|
Tyler Jacks Director |
SELL
Open market or private sale
|
Direct |
20,000
-69.02%
|
$3,900,000
$195.41 P/Share
|
|
Dec 06
2018
|
Tyler Jacks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+40.83%
|
$1,640,000
$82.6 P/Share
|
|
Nov 30
2018
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
4,109
-9.11%
|
$830,018
$202.37 P/Share
|
|
Nov 30
2018
|
David Piacquad SVP, Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+12.59%
|
$351,000
$54.69 P/Share
|
|
Nov 29
2018
|
Cynthia M Patton SVP & CCO |
SELL
Open market or private sale
|
Direct |
1,777
-7.7%
|
$358,954
$202.88 P/Share
|
|
Nov 29
2018
|
Cynthia M Patton SVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,777
+7.15%
|
$95,958
$54.69 P/Share
|
|
Nov 05
2018
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
93
+6.12%
|
-
|
|
Nov 02
2018
|
Murdo Gordon EVP, Global Commercial Ops |
BUY
Grant, award, or other acquisition
|
Direct |
34,213
+50.0%
|
-
|
|
Nov 02
2018
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
149
+4.31%
|
-
|
|
Nov 02
2018
|
David M Reese EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,830
+29.53%
|
-
|
|
Aug 10
2018
|
Rebecca M Henderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
977
-6.03%
|
$188,561
$193.97 P/Share
|
|
Aug 10
2018
|
Rebecca M Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+15.63%
|
$189,000
$63.11 P/Share
|
|
Aug 06
2018
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,586
-13.77%
|
$1,297,442
$197.99 P/Share
|
|
Aug 01
2018
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,382
-12.39%
|
$1,446,872
$196.55 P/Share
|
|
Aug 01
2018
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,982
-5.41%
|
$388,472
$196.55 P/Share
|
|
Jul 31
2018
|
Brian Druker Director |
BUY
Grant, award, or other acquisition
|
Direct |
678
+50.0%
|
-
|
|
Jul 31
2018
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
89
+3.33%
|
-
|
|
Jul 31
2018
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+4.61%
|
-
|
|
Jul 16
2018
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.65%
|
$297,375
$195.71 P/Share
|
|
Jun 12
2018
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.58%
|
$280,600
$184.27 P/Share
|
|
May 14
2018
|
Sean E Harper EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
1,525
-2.52%
|
$265,350
$174.1 P/Share
|
|
May 11
2018
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
9,860
-19.12%
|
$1,676,200
$170.77 P/Share
|
|
May 11
2018
|
David Piacquad SVP, Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+22.53%
|
$810,000
$54.71 P/Share
|
|
May 03
2018
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,312
-0.53%
|
$390,728
$169.43 P/Share
|
|
May 03
2018
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
390
-0.82%
|
$65,910
$169.43 P/Share
|
|
May 03
2018
|
Sean E Harper EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
736
-1.2%
|
$124,384
$169.43 P/Share
|
|
May 03
2018
|
Anthony C Hooper EVP, Global Commercial Ops. |
SELL
Payment of exercise price or tax liability
|
Direct |
883
-0.41%
|
$149,227
$169.43 P/Share
|
|
May 03
2018
|
David W Meline EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
773
-1.29%
|
$130,637
$169.43 P/Share
|
|
May 03
2018
|
Cynthia M Patton SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.69%
|
$28,561
$169.43 P/Share
|
|
May 03
2018
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.48%
|
$30,082
$169.43 P/Share
|
|
May 03
2018
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.49%
|
$30,082
$169.43 P/Share
|
|
Apr 27
2018
|
Wanda M Austin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+48.0%
|
-
|
|
Apr 27
2018
|
David Baltimore Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+3.37%
|
-
|
|
Apr 27
2018
|
Francois De Carbonnel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
260
-1.56%
|
$45,500
$175.37 P/Share
|
|
Apr 27
2018
|
Francois De Carbonnel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+6.33%
|
-
|
|
Apr 27
2018
|
Robert Eckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+10.62%
|
-
|
|
Apr 27
2018
|
Greg C. Garland Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+13.78%
|
-
|
|
Apr 27
2018
|
Fred Hassan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+13.51%
|
-
|
|
Apr 27
2018
|
Rebecca M Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+7.92%
|
-
|
|
Apr 27
2018
|
Frank C Herringer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+2.17%
|
-
|
|
Apr 27
2018
|
Charles M Holley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,228
+33.05%
|
-
|
|
Apr 27
2018
|
Tyler Jacks Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+11.26%
|
-
|
|
Apr 27
2018
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,301
+30.43%
|
-
|
|
Apr 27
2018
|
Ronald D Sugar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+8.14%
|
-
|
|
Apr 27
2018
|
R Sanders Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+17.99%
|
-
|
|
Apr 27
2018
|
Robert A Bradway Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
14,087
+3.15%
|
-
|
|
Apr 27
2018
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
3,155
+6.2%
|
-
|
|
Apr 27
2018
|
Sean E Harper EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
4,508
+6.85%
|
-
|